Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Cancers|October 15, 2020
Dendrogenin A Enhances Anti-Leukemic Effect of Anthracycline in Acute Myeloid LeukemiaPierre-Luc Mouchel, Nizar Serhan, Rémy Betous, et al.
Biochemical Pharmacology|March 19, 2013
5,6-Epoxy-cholesterols contribute to the anticancer pharmacology of tamoxifen in breast cancer cellsGregory Segala, Philippe de Medina, Luigi Iuliano, et al.
The Journal of Steroid Biochemistry and Molecular Biology|April 9, 2019
Flavonoids differentially modulate liver X receptors activity-Structure-function relationship analysisAllan Fouache, Nada Zabaiou, Cyrille De Joussineau, et al.
Autophagy|June 1, 2012
MAPK14/p38α confers irinotecan resistance to TP53-defective cells by inducing survival autophagySalome Paillas, Annick Causse, Laetitia Marzi, et al.
Journal of Personalized Medicine|May 27, 2023
An Update on Tamoxifen and the Chemo-Preventive Potential of Vitamin E in Breast Cancer ManagementFarid Khallouki, Lhoussain Hajji, Somayya Saber, et al.
Journal of Extracellular Vesicles|April 12, 2022
Targeting the liver X receptor with dendrogenin A differentiates tumour cells to secrete immunogenic exosome-enriched vesiclesMichel Record, Mehdi Attia, Kevin Carayon, et al.
Nature Communications|May 16, 2013
Dendrogenin A arises from cholesterol and histamine metabolism and shows cell differentiation and anti-tumour propertiesPhilippe de Medina, Michael R Paillasse, Gregory Segala, et al.
Pageof 9